跳至主要内容
临床试验/NCT00689364
NCT00689364Unknown不适用

Retrospective-Prospective Cohort Study Effectiveness of Comprehensive Therapy of TCM to Relieving the Risk of Recurrence and Metastasis for Stage II & III Colorectal Cancer Based on Conventional Western Medicine Therapy

Ministry of Science and Technology of the People´s Republic of China1 个研究点 分布在 1 个国家目标入组 480 人开始时间: 2007年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
480
试验地点
1
主要终点
The recurrence and metastasis rates for 1、2、3、4 and 5-year.

研究概览

简要总结

Comprehensive therapy of traditional Chinese medicine (CTTCM) could relieve risk of recurrence and metastasis for stage II & III colorectal cancer, the investigators take this clinical trial with retrospective-prospective cohort study based on previous studies by international multi-center way.

If the study shows a positive result, a pragmatic randomized controlled study with prospective, multi-centre and large-sample design will be given continuously. The aim is to establish recommended programs suggested by CTTCM strategies under conventional Western medicine therapy (CWMT) for stage II & III colorectal cancer.

详细描述

CTTCM: taking TCM decoction based on syndrome differentiation daily and each dosage is decocted two times for intervention one year with a Chinese patent medicine at least.

CWMT: with or without chemotherapy/or radiotherapy after the radical operation (R0) (according to the latest NCCN clinical guideline).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient who is diagnosed colorectal cancer by patho& cytologic diagnosis since accepting radical operation within half a year.
  • Stage II or III colorectal cancer.
  • 18-75 yr.
  • Being able to participate and sign the informed consent.

排除标准

  • Pregnant woman, Psychotic.
  • Patient who put together with other cancer.
  • Existed serious complaint and functional disturbance (impairment) with non-tumorous in arch-organ.
  • Reactiveness cerebrovascular disease (CVD) .
  • Uncontrolled infection and metabolic disease.
  • One item of tumor marks is progressed, and it still is progressed when patient recheck.
  • Tumor that it is neo-occurred in each organ or pelvic cavity or abdominal cavity without definite patho-quality.

结局指标

主要结局

The recurrence and metastasis rates for 1、2、3、4 and 5-year.

时间窗: one year

次要结局

  • Survival index: the survival rate for1、2、3、4 and 5-year.(one year)

研究者

发起方
Ministry of Science and Technology of the People´s Republic of China
申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验